Open Access

Total intravenous anaesthesia in a goat undergoing craniectomy

BMC Veterinary ResearchBMC series – open, inclusive and trusted201713:287

https://doi.org/10.1186/s12917-017-1205-2

Received: 9 May 2016

Accepted: 7 September 2017

Published: 15 September 2017

Abstract

Background

Cerebral coenurosis is a disease of the central nervous system in sheep and goats, and is usually fatal unless surgical relief is provided. Information regarding neuroanaesthesia in veterinary medicine in goats is scant.

Case presentation

We describe anaesthetic management of an intact female goat (2 years; 16 kg) presented for craniectomy. The goat was sedated with xylazine (0.05 mg kg−1, i.m.) and morphine (0.05 mg kg−1, i.m.). General anaesthesia was induced 20 min later with propofol and maintained with a constant rate infusion of propofol (0.2 mg kg−1 min−1). A cuffed endotracheal tube was placed and connected to a rebreathing (circle) system and mechanical ventilation with 100% oxygen was initiated. A bolus of lidocaine (1 mg kg−1), midazolam (0.25 mg kg−1) and fentanyl 2.5 μg kg−1 was delivered via the intravenous route followed immediately by a constant rate infusion of lidocaine (50 μg kg−1 min−1), midazolam (0.15 mg kg−1 h−1) and fentanyl (6 μg kg−1 h−1) administered via the intravenous route throughout surgery. Craniectomy was undertaken and the goat recovered uneventfully.

Conclusion

Total intravenous anaesthesia with propofol, lidocaine, fentanyl and midazolam could be an acceptable option for anaesthesia during intracranial surgery in goats.

Keywords

Goat Propofol Fentanyl Lidocaine Midazolam Craniectomy Total intravenous anaesthesia

Background

Cerebral coenurosis is a disease of the central nervous system (CNS) in sheep and goats. Due to development of the cyst in brain, the animal starts showing nervous signs that include circling, visual defects, gait abnormalities, hyperesthesia, and paraplegia [1]. Surgical removal is the only available treatment. However, there are few reports of surgical treatment [14] and only brief descriptions of anaesthetic management. In those studies, goats were sedated [3] or controlled manually by an assistant [2] while surgery was undertaken under local anaesthesia. Only Merbl et al. [1] described two cases of constant rate infusion (CRI) of propofol and fentanyl.

Anaesthesia for intracranial neurosurgical procedures must provide haemodynamic stability, maintain cerebral perfusion pressure (CPP), reduce the cerebral metabolic rate (CMR), preserve cerebral autoregulation and avoid an increase in intracranial pressure (ICP) [5]. Anaesthesiologists must plan for smooth emergence, rapid awakening, and early neurological assessment of the patient in the postoperative period [6].

Volatile and intravenous anaesthetic agents are used for the maintenance of anaesthesia during neurosurgical procedures. Which type of anaesthetic (inhalational or intravenous) is preferable for a craniectomy is controversial. Volatile anaesthetics are dose-dependent cerebral vasodilators that affect cerebral autoregulation and ICP [7]. However, most intravenous anaesthetic, analgesic and sedative agents maintain a linear relationship between a reduction in cerebral blood flow (CBF) and CMR, autoregulation of cerebral perfusion and CO2 responsiveness, and have minimal effects on ICP [7].

In human medicine propofol does not interfere with CBF regulation [8] and decreases CMR, which stimulates vasoconstriction and results in decreased ICP in rats [9]. Clinical studies have suggested that propofol alone or in combination with alfentanil can aid the maintenance of anaesthesia during craniotomy in human beings [10].

Pure mu-agonist opioids (e.g. fentanyl) are commonly used for analgesia in balanced total intravenous anaesthesia (TIVA) and can attenuate nociceptive signals from noxious stimuli at subcortical levels of the CNS [11]. In goats, fentanyl has been shown to be effective against thermal and mechanical stimuli using a model of nociception [12].

Benzodiazepines such as midazolam contribute to TIVA through sedation and muscle relaxation [13]. Midazolam has been reported to be a potent sedative drug [14] that can be administered during the pre-anaesthetic period to reduce the dose of propofol required for induction of general anaesthesia in goats [15].

Intravenous lidocaine has been used as a supplement to general anaesthesia, and its perioperative administration reduces postoperative pain. Intravenous lidocaine has been shown to reduce the minimum alveolar concentration of isoflurane in dogs [16], cats [17], horses [18] and goats [19].

There is limited information regarding neuroanaesthesia in veterinary medicine. Moreover, goats are anaesthetised rarely, so information on the efficacy of anaesthetic drugs in this species is scant [13]. Maintenance of anaesthesia using propofol administered by CRI in combination with other injectable drugs or inhalation agents has been reported in goats [1921]. Fentanyl, midazolam [21] and ketamine [20] have been shown to be anaesthetic-sparing agents that lower the propofol dose required for the maintenance of anaesthesia.

Here, we describe anaesthetic management in a goat undergoing resection of an intracranial coenurosis. Concurrent use of propofol, fentanyl, lidocaine and midazolam in goats has not been reported.

Case description

An intact female goat (2 years old; 16 kg) was admitted to hospital for investigation of neurological signs. Behavioural disturbances, standing apart from other goats, and disorientation were observed. Furthermore, it seemed to be very easy to chase and catch the goat.

General physical examination was unremarkable. However, upon neurological examination, an absent left-sided menace response, alert mentation and head tilt were noted. No other abnormalities were noted and the results of haematology and blood biochemistry were unremarkable. Magnetic resonance imaging (MRI; Vet-MR Grande; Esaote S.A., Barcelona, Spain) of the brain revealed a cystic lesion at the level of the right cerebral hemisphere (Fig. 1). The goat was scheduled for resection of this lesion.
Fig. 1

Axial T1 magnetic resonance image showing a hypointense lesion occupying most of the right hemisphere suspected to be a cerebral cyst

The goat was anaesthetised for surgery. Food (but not water) was withheld 12 h before anaesthesia. The goat was pre-medicated with xylazine (0.05 mg kg−1, i.m.; Rompun 2% soluble injection; Bayer, Barcelona, Spain) and morphine (0.05 mg kg−1, i.m.; Morfina 1%; Fresenius Kabi España S.A., Barcelona, Spain) 20 min before the induction of anaesthesia. A 20-G catheter (BD Insyte; Becton Dickinson Medicals Pte. Ltd., Singapore) was inserted into the cephalic vein for the administration of drugs and intravenous fluids. An antibiotic (ampicillin, 20 mg kg−1, i.v.; Britapen, 500-mg soluble injection; Reig Jofre S.A., Madrid, Spain) was given and administration repeated every 90 min throughout the surgical procedure. The auricular artery in the left ear was catheterised using a 24-G catheter. Five minutes before the induction of anaesthesia, the goat underwent pre-oxygenation via a facemask with 100% oxygen. Before the induction of anaesthesia, the degree of sedation was moderate. Propofol (Vetofol, 10 mg mL−1; Esteve, Barcelona, Spain) was administered initially as a bolus at 2 mg kg−1 over 30 s, followed by incremental doses at 0.5 mg kg−1 every 15 s, until the goat was anaesthetised sufficiently to allow endotracheal intubation (total dose, 50 mg). A cuffed, 6.5-mm ID endotracheal tube was placed and connected to a rebreathing (circle) system. Intermittent positive pressure ventilation (IPPV) with 100% oxygen was initiated using a pressure-cycled mechanical ventilator (ABC; Stephan GmbH, Gackenbach, Germany). Peak inspiratory pressure (PIP) was set at 8–10 cmH2O, and the respiratory rate (f R) adjusted to maintain a partial pressure of expired carbon dioxide (PE′CO2) at 33–35 mmHg.

The goat was placed in sternal recumbency for preparation of the surgical site with the head elevated at 30°. Occlusion of the jugular vein was avoided throughout the procedure. The goat was connected to a multi-parameter anaesthesia monitor (S/5; Datex-Ohmeda, Inc., Madison, WI, USA), which displayed continuously a lead-II electrocardiogram, heart rate (HR), f R, PE′CO2, inspired fraction of oxygen, tidal volume, invasive blood pressure (IBP), PIP, dynamic respiratory system compliance and plethysmographic oxygen saturation (SpO2). The catheter in the auricular artery was connected to an electronic pressure transducer (Deltran DPT-200; Utah Medical Products, Inc., Midvale, UT, USA) zeroed at the level of shoulder joint to measure IBP. Body temperature was measured using an intra-oesophageal temperature probe and displayed continuously on the multi-parameter monitor.

A CRI of propofol (6 mg kg−1 h−1) was started immediately after the induction of anaesthesia. Additionally, a bolus of lidocaine (1 mg kg−1; Lidocaína 2% soluble injection; B. Braun Medical S.A., Barcelona, Spain), midazolam (0.25 mg kg−1; Dormicum 5 mg mL−1 soluble injection; Roche Farma S.A., Madrid, Spain) and fentanyl (2.5 μg kg−1, Fentanest 0.05 mg mL−1 soluble injection; Kern Pharma, Barcelona, Spain) were delivered (i.v.) by hand over 60 s, followed immediately by a CRI of lidocaine (50 μg kg−1 min−1), midazolam (0.15 mg kg−1 h−1) and fentanyl (6 μg kg−1 h−1) administered via the intravenous route throughout the surgical procedure. Propofol and fentanyl for CRI were drawn up to fill a 20-mL syringe (Perfusor Compact; B. Braun Medical S.A.), whereas 600 mg of lidocaine and 30 mg of midazolam were mixed in 1 L of lactated Ringer’s solution (Ringer Lactato; B. Braun Medical S.A.) and infused together with a volumetric pump (Niki: C.M.E. Ltd., Lichtenstein, Germany) at 5 mL kg−1 h−1.

The criteria used to assess the depth of anaesthesia were HR, IBP, attempts to breathe against the ventilator and spontaneous movement. According to clinical signs, CRI of propofol was increased to 12 mg kg−1 h−1 10 min after the induction of anaesthesia. Lactated Ringer’s solution was infused via the intravenous route during surgery at 5 mL kg−1 h−1. A bolus of propofol (0.5 mg kg−1, i.v.) was administered if voluntary movement occurred. The infusion rate of propofol was recorded every 5 min, along with all physiological parameters displayed on the multi-parametric monitor.

Samples of arterial blood were collected anaerobically from the arterial catheter. They were analysed immediately and 45 min after the induction of anaesthesia to ensure blood gases remained within established reference ranges (PaCO2, 39.5 mmHg; PaO2, 475 mmHg; HCO3, 29.5 mmol L−1; base excess, 5 mmol L−1; SaO2, 100%; pH 7.481; lactate, 0.88 mmol L−1).

TIVA provided adequate cardiovascular stability (HR, 76–96 bpm) and adequate arterial blood pressure (Fig. 2) throughout anaesthesia (mean arterial blood pressure (MAP), 75–90 mmHg). Regurgitation, hyper-salivation and tympany were not observed. Oesophageal temperature decreased gradually over the period of anaesthesia but hypothermia (36.1 °C) was not corrected until the end of the procedure.
Fig. 2

Heart rate (bpm) and mean arterial blood pressure (mmHg) in a goat undergoing craniectomy anaesthetized with TIVA of propofol, lidocaine, fentanyl and midazolam. Square marks the beginning of surgery

Craniectomy was undertaken to remove the cyst. Five minutes before completion of surgery, a bolus of dexamethasone (0.3 mg kg−1, i.v.; Cortesona 2 mg mL−1 soluble injection; Laboratorios Syva, León, Spain) and acepromazine (0.02 mg, i.v.; Equipromacina 5 mg mL−1 soluble injection; Labiana Life Sciences, S.A., Barcelona, Spain) were administered to ensure a smooth recovery. After skin closure, all CRI was stopped (total dose of propofol, 310 mg). IPPV was continued until attempts were made to breathe spontaneously. Then, the goat was moved in sternal recumbency to the recovery room. To avoid complications associated with the digestive tract and respiratory system, the goat was supported in sternal recumbency and the endotracheal tube removed only after return of the swallowing reflex (20 min after the end of the surgery). Total anaesthesia time (from the induction of anaesthesia to TIVA cessation) was 90 min. The goat recovered uneventfully from anaesthesia and could stand and eat <24 h after surgery.

Assessment of pain and physiological variables was conducted every hour until hospital discharge: no abnormalities were detected. Immediate postoperative care comprised administration of dexamethasone (0.1 mg kg−1, i.v.) every 24 h, buprenorphine (0.005 mg kg−1, i.v.; Buprecare 0. 3 mg mL−1 soluble injection; Group Divasa-Farmavic, Barcelona, Spain) every 8 h, head elevation, intravenous fluid therapy (Sterovet; B. Braun Vetcare S.A., Barcelona, Spain) to maintain normotension and regular evaluation of neurological status. Neurological examination was done 24 h after surgery and revealed no worsening of neurological deficits. Neurological signs improved within 5 days and resolved upon hospital discharge (14 days after surgery).

Discussion

Wider availability of imaging methods (e.g. MRI) to veterinary surgeons and the growing popularity of having goats as domestic pets have resulted in more goats requiring surgery that involves general anaesthesia. Recommendations for patients with intracranial neoplasms have not been determined and management has been extrapolated from studies in head-trauma patients [22]. Many methods for anaesthesia in animals with CNS disease have been reported, but their cerebrovascular effects are unknown.

The main aim of any anaesthetic method used for intracranial surgery is preservation of neuronal function [22]. The latter is dependent upon adequate CBF, which in turn is dependent on the CPP and cerebral vascular resistance (CVR). CPP is defined as the difference between MAP at the level of the base of the brain and ICP. In patients with increased intracranial pressure, it is vital to consider the changes that a decrease in blood pressure may have in CPP [23], so maintaining adequate and stable cardiovascular function is essential.

Tracheal intubation can stimulate coughing and gagging, as well as a reflex sympathetic pressor response, which results in an elevated HR and blood pressure in humans [24], dogs [25] and cats [26]. This reflex may have adverse effects in patients with increased ICP.

Intravenous lidocaine has been used in humans at 1.5–2.5 mg kg−1 at least 3 min before the induction of anaesthesia to blunt the haemodynamic and coughing responses to tracheal intubation [27]. In this case, lidocaine administration before intubation to minimise the pressor response to intubation (as has been described in humans) was not done, but non-significant changes were observed in the HR or MAP after intubation. In this case, propofol provided a smooth induction of anaesthesia with no apnoea or myoclonus, as have been reported elsewhere [15, 28].

The position of the head can aid or worsen the control of ICP. Head elevation by 15–30° can improve cerebral venous drainage and limit cerebral venous congestion, thereby reducing ICP without reducing CPP or CBF [29]. Therefore, maintenance of this position is recommended if an increase in ICP is suspected. Occlusion of the jugular vein can impair venous drainage to cause increased ICP. Jugular catheterisation of patients at risk of raised ICP is controversial [29], so we avoided measuring CVP in this case.

In this case, we preferred lactated Ringer’s solution to ensure electrolyte balance despite being a slightly hypotonic fluid and could therefore cause oedema. The MRI did not show evidence of oedema in the surrounding tissue, for this reason we avoided using mannitol preoperatively (as has been recommended). However we used corticosteroids perioperatively to maintain adequate CPP by reducing peri-cyst oedema after surgery, as has been described in the treatment of brain tumours [30].

In the absence of direct monitoring of ICP, it is recommended that a MAP of 80–100 mmHg be maintained to ensure adequate CPP [31]. Maintenance of an adequate depth of anaesthesia to avoid hypotension is very important. In this case, MAP was >80 mmHg most of the time (Fig. 2). Elevated ICP could be a problem until reduction in ICP occurs after durotomy, but no treatment was initiated to increase MAP. Because of the positioning of the animal for surgery, the eye position, jaw tone and palpebral reflexes could not be used to assess the depth of anaesthesia. Furthermore, the usefulness of MAP and HR in the assessment of the depth of anaesthesia is confounded by the effects of anaesthetic agents on cardiovascular function [22]. Despite such difficulties in the assessment of the depth of anaesthesia, the goat started to breathe against the ventilator and received a bolus of propofol only once. In human medicine, electroencephalography is useful for monitoring the adequacy of sedation and anaesthesia during neurosurgery, but an electroencephalograph was not available in our hospital.

The PaCO2 is an important factor for the control of CVR and CBF. An acute rise in PaCO2 can cause a decrease in arteriolar pH, which results in decreased CVR and which increases CBF. In contrast, hypocapnia results in intracranial vasoconstriction and decreased cerebral perfusion [29]. IPPV is mandatory in neurosurgical patients to prevent increases in PaCO2 as well as the associated vasodilatation and increased ICP [32]. Improvements in MAP and CPP may also be achieved by limiting the detrimental effects of IPPV upon venous return and cardiac output [22]. IPPV can increase central venous pressure (CVP) and decrease venous drainage from the head, thereby leading to venous congestion, increased ICP and further reductions in CPP [32]. Court et al. [33] proposed that this effect could be minimised by using neuromuscular blocking agents that increase thoracic compliance and thus decrease the intrathoracic pressure required to ventilate the animal adequately. In this case, we avoided neuromuscular blocking agents but muscle relaxation was sufficient to ensure adequate IPPV with no apparent cardiovascular effects.

Interest in TIVA for neuroanaesthesia has been well documented in the literature on human medicine [10]. Research on TIVA in goats has become increasingly popular over the past few years [13, 21, 34]. However, information on TIVA protocols applicable to goats is very scarce [34].

Pharmacokinetic studies in various species have revealed that propofol has a large volume of distribution, rapid metabolism and rapid clearance if given by repeated doses or continuous intravenous infusion [28, 35, 36]. The rapid onset, short duration of action and rapid recoveries make this drug potentially useful in ruminants, in which these features are particularly desirable [37]. Plasma clearance of propofol in goats is rapid and exceeds the rate clearance in dogs, horses and humans [36]. Propofol has been used as a continuous intravenous infusion to achieve and maintain general anaesthesia in goats [1, 1921].

The minimum infusion rate of propofol to prevent purposeful movement of the extremities in response to a standardised noxious stimulus in non-premedicated goats is 0.45 mg kg−1 min−1 [38]. In studies undertaken by Dzikiti et al. [39] and Larenza et al. [20], infusion rates of propofol of 0.2 and 0.3 mg kg−1 min−1, respectively, were reported. Both studies co-administrated anaesthetic-sparing agents (fentanyl, midazolam [39]; ketamine [20]), to lower the infusion rates of propofol required to maintain anaesthesia. Nevertheless, Carroll et al. [40] reported a higher dose rate (0.52 mg kg−1 min−1) in pre-medicated (detomidine and butorphanol) goats undergoing orchiectomy and ovariectomy, perhaps because surgical stimulation may exceed the standardised supramaximal stimulus applied in research studies. In our case, the CRI of propofol was 0.2 mg kg−1 min−1, this can be explain for co-administration of lidocaine, midazolam and fentanyl CRI.

Midazolam produces a rapid onset of short-duration, dose-dependent sedation in goats [14, 15] and decreases the induction doses of propofol required [15]. It is associated with minimal adverse cardiovascular effects if administered as pre-anaesthetic medication [15] and at 0.1–0.9 mg kg−1 h−1 for an adjunctive role to general anaesthetic drugs in goats [21, 39]. Midazolam produces marked reductions in drug requirements for general anaesthesia in inhalation and intravenous anaesthesia in goats [21, 39, 41]. Sedative effects of midazolam in goats are dose dependent, therefore, in this case, a higher dose of midazolam might have been used to further decrease the dose of propofol required for maintenance.

Lidocaine was infused immediately after intubation throughout surgery to elicit neuroprotective and analgesic effects. Lidocaine may reduce secondary brain injury by preventing sodium influx into ischemic neurons [42]. Evidence suggests that infusion of an antiarrhythmic dose (1.5–2 mg kg−1) after the onset of brain ischemia reduces the risk of death of neuronal cells and improves neurologic outcome [43].

The synthetic μ-opioid agonist fentanyl is used for the treatment of moderate-to-severe pain. Fentanyl administered via the intravenous route as CRI after a bolus dose could be a useful analgesic adjunct to general anaesthesia in goats [39]. Fentanyl causes minimal adverse effects on cardiopulmonary function in goats, but has been associated with restlessness, increased vocalisation and exaggerated tail wagging during recovery from anaesthesia [39]. Although we used a low dose of fentanyl, to avoid these possible adverse effects and to ensure a smooth recovery and more compliant animal in the postoperative period, a small dose of acepromazine was administered at the end of the surgery. Despite that acepromazine should cause hypotension and vasodilatation and presumably decrease of CPP, we believe that the effects of an excited recovery would be even more damaging in this goat.

In our case, the recovery time was short and adverse effects such as myoclonus (which has been reported in goats recovering from a single dose of propofol [15]) was not observed, unlike in studies were CRI of propofol was used to maintain anaesthesia [21]. One important feature of a neuroanaesthetic protocol is rapid recovery from anaesthesia to allow prompt neurological assessment [10]. Rapid predictable recovery with minimal excitement regardless of the duration of anaesthesia is required to identify postoperative complications (e.g. haemorrhage, increased ICP) and prevent severe neurological impairment and death [23]. Moreover, rapid recovery from anaesthesia is important in ruminants because they are prone to tympany and regurgitation of ruminal contents, which increases the risk of hypoxemia and aspiration of regurgitated ruminal contents [37].

Conclusion

We reported on anaesthetic management in a goat undergoing surgical treatment for cerebral coenurosis. This is the first report of CRI of propofol, lidocaine midazolam and fentanyl in goats. TIVA (achieved by co-administration of propofol, lidocaine, midazolam and fentanyl) for the maintenance of anaesthesia in a ventilated oxygen-supplemented goat undergoing craniectomy resulted in satisfactory anaesthesia with minimal negative impact on cardiopulmonary function as well as good recovery. This method could be an acceptable option for anaesthesia during intracranial surgery in goats.

Abbreviations

CBF: 

Cerebral blood flow

CMR: 

Cerebral metabolic rate

CNS: 

Central nervous system

CPP: 

Cerebral perfusion pressure

CRI: 

Continuous rate infusion

CVP: 

Central venous pressure

CVR: 

Cerebral vascular resistance

f R

Respiratory rate

HR: 

Heart rate

IBP: 

Invasive blood pressure

ICP: 

Intracranial pressure

IPPV: 

Intermittent positive pressure ventilation

MAP: 

Mean arterial blood pressure

PIP: 

Peak inspiratory pressure

SpO2

Plethysmographic oxygen saturation

TIVA: 

Total intravenous anaesthesia

PE′CO2

Partial pressure of expired carbon dioxide

Declarations

Authors’ contributions

All authors were implicated in the clinical management of the case. VV drafted the manuscript and provided the figures. All authors revised it critically, provided helpful discussions and final corrections on the manuscript. They read and approved the final version of this manuscript.

Competing interests

The authors declare that they have no competing interests.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

(1)
Veterinary Teaching Hospital, University of Extremadura
(2)
Department of Animal Medicine and Surgery, Veterinary Faculty, University Complutense of Madrid

References

  1. Merbl Y, Shilo-Benjamini Y, Chai O, Chamisha Y, Anglister N, King R, Horowitz I, Aizenberg Z, Shamir MH. Taenia multiceps brain cyst removal in two wild Nubian ibex (Capra nubianas). J Zoo Wildl Med. 2014;45(1):193–6.View ArticlePubMedGoogle Scholar
  2. Amin MN, Hashim MA, Hossain MA, Al-Sultan II. Coenurus cerebralis infection (Gid disease) in Black Bengal goats; Effects on certain blood values after surgical treatment. JABPA. 2013;3(1):1–7.Google Scholar
  3. Biswas D. Ultrasound diagnosis and surgical treatment of coenurosis (GID) in bengal goat (Capra hircus) at chittagong metropolitan area, Chittagong, Bangladesh. Sci J Vet Adv. 2013;2:68–75.Google Scholar
  4. Komnenou A, Argyroudis S, Giadinis N, Dessiris A. Surgical treatment of coenurosis (gid) in sheep. Vet Rec. 2000;147(9):242–4.View ArticlePubMedGoogle Scholar
  5. Weglinski MR, Perkins WJ. Inhalational versus total intravenous anes- thesia for neurosurgery: Theory guides, outcome decides. J Neurosurg Anesthesiol. 1994;6:290–3.View ArticlePubMedGoogle Scholar
  6. Banevičius G, Rugytė D, Macas A, Tamašauskas A, Stankevičius E. The effects of sevoflurane and propofol on cerebral hemodynamics during intracranial tumors surgery under monitoring the depth of anesthesia. Medicina (Kaunas). 2010;46(11):743–52.Google Scholar
  7. Matta BF, Heath KJ, Tipping K, Summors AC. Direct cerebral vaso- dilatory effects of sevoflurane and isoflurane. Anesthesiology. 1999;91:677–80.View ArticlePubMedGoogle Scholar
  8. Matta BF, Lam AM, Strebel S, Mayberg TS. Cerebral pres- sure autoregulation and carbon dioxide reactivity dur- ing propofol-induced EEG suppression. Br J Anaesth. 1995;74(2):159–63.View ArticlePubMedGoogle Scholar
  9. Souter MJ, Andrews PJD, Piper IR, Miller JD. Effects of alfentanil on cerebral haemodynamics in an experimental model of traumatic brain injury. Br J Anaesth. 1997;79:97–102.View ArticlePubMedGoogle Scholar
  10. Coles JP, Leary TS, Monteiro JN, Brazier P, Summors A, Doyle P, Matta BF, Gupta AK. Propofol anesthesia for cra- niotomy: A double-blind comparison of remifentanil, alfentanil, and fentanyl. J Neurosurg Anesthesiol. 2000;12:15–20.View ArticlePubMedGoogle Scholar
  11. Bouillon TW, Bruhn J, Radulescu L, Andresen C, Shafer TJ. Pharmacodynamic interaction between propofol and remifentanil regarding hypnosis, tolerance of laryngoscopy, bispectral index, and electroence- phalographic approximate entropy. Anesthesiology. 2004;100:1353–72.View ArticlePubMedGoogle Scholar
  12. Valverde A, Gunkel CI. Clinical practice review: pain management in horses and farm animals. J Emerg Crit Care. 2005;15:295–307.View ArticleGoogle Scholar
  13. Dzikiti TB, Ndawana PS, Zeiler G, Bester L, Dzikiti LN. Determination of the minimum infusion rate of alfaxalone during its co-administration with midazolam in goats. Vet Rec Open. 2015 Feb 25;2(1):e000065. https://doi.org/10.1136/vetreco-2014-000065.View ArticlePubMedPubMed CentralGoogle Scholar
  14. Stegmann GF, Bester L. Sedative-hypnotic effects of midazolam in goats after intravenous and intramuscular administration. Vet Anaesth Analg. 2001;28:49–55.View ArticlePubMedGoogle Scholar
  15. Dzikiti TB, Stegmann GF, Hellebrekers LJ, Auer RE, Dzikiti LN. Sedative and cardiopulmonary effects of acepromazine, midazolam, acepromazine-butorphanol and midazolam- butorphanol on propofol anaesthesia in goats. J S Afr Vet Assoc. 2009;80(1):10–6.PubMedGoogle Scholar
  16. Valverde A, Doherty TJ, Hernandez WD. Effect of intravenous lidocaine on isoflurane MAC in dogs. Vet Anaesth Analg. 2004;31:264–71.View ArticlePubMedGoogle Scholar
  17. Pypendop BH, Ilkiw JE. The effects of intravenous lidocaine administration on the minimum alveolar concentration of isoflurane in cats. Anesth Analg. 2005;100:97–101.View ArticlePubMedGoogle Scholar
  18. Dzikiti TB, Hellebrekers LJ, van Dijk P. Effects of intravenous lidocaine on isoflurane concentration, physiological parameters, metabolic parameters and stress-related hormones in horses undergoing surgery. J Am Vet Med Assoc. 2003;50:190–5.View ArticleGoogle Scholar
  19. Doherty T, Redua MA, Queiroz-Castro P, Egger C, Cox SK, Rohrbach BW. Effect of intravenous lidocaine and ketamine on the minimum alveolar concentration of isoflurane in goats. Vet Anaesth Analg. 2007;34:125–31.View ArticlePubMedGoogle Scholar
  20. Larenza MP, Bergadano A, Iff I, Doherr MG, Schatzman U. Comparison of the cardiopulmonary effects of anaesthesia maintained by continuous infusion of ketamine and propofol with anaesthesia maintained by inhalation of sevoflurane in goats undergoing magnetic resonance imaging. Am J Vet Res. 2005;66:2135–41.View ArticlePubMedGoogle Scholar
  21. Dzikiti TB, Stegmann FG, Dzikiti LN, Hellebrekers LJ. Total intravenous anaesthesia (TIVA) with propofol–fentanyl and propofol–midazolam combinations in spontaneously breathing goats. Vet Anaesth Analg. 2010;37:519–25.View ArticlePubMedGoogle Scholar
  22. Raisis AL, Leece EA, Platt SR, Adams VJ, Corletto F, Brearley J. Evaluation of an anaesthetic technique used in dogs undergoing craniectomy for tumour resection. Vet Anaesth Analg. 2007;34:171–80.View ArticlePubMedGoogle Scholar
  23. Bruder NJ. Awakening management after neuro- surgery for intracranial tumours. Curr Opin Anaes- thesiol. 2002;15:477–82.View ArticleGoogle Scholar
  24. Gurulingappa AMA, Awati MN, Adarsh S. Attenuation of cardiovascular responses to direct laryngoscopy and intubation — A comparative study between IV bolus fentanyl, lignocaine and placebo (NS). J Clin Diagn Res. 2012;6:1749–52.PubMedPubMed CentralGoogle Scholar
  25. Jolliffe CT, Leece EA, Adams V, Marlin DJ. Effect of intravenous lidocaine on heart rate, systolic arterial blood pressure and cough responses to endotracheal intubation in propofol-anaesthetized dogs. Vet Anaesth Analg. 2007;34:322–30.View ArticlePubMedGoogle Scholar
  26. Tomori Z, Widdicombe JG. Muscular, bronchomotor and cardiovascular reflexes elicited by mechanical stimulation of the respiratory tract. J Physiol. 1969;200:25.View ArticlePubMedPubMed CentralGoogle Scholar
  27. Sun L, Guo R, Sun L. The impact of prophylactic intravenous lidocaine on opioid-induced cough: A meta-analysis of randomized controlled trials. J Anesth. 2014;28:325–33.View ArticlePubMedGoogle Scholar
  28. Bettschart-Wolfensberger R, Semder A, Alibhai H, Demuth D, Aliabadi FS, Clarke KW. Cardiopulmonary side-effects and pharmacokinetics of an emulsion of propofol (Disoprivan) in comparison to propofol solved in polysorbate 80 in goats. J Vet Med A Physiol Pathol Clin Med. 2000;47:341–50.View ArticlePubMedGoogle Scholar
  29. Armitage-Chan EA, Wetmore LA, Chan DL. Anesthetic management of the head trauma patient. J Vet Emerg Crit Care. 2007;17:5–14.View ArticleGoogle Scholar
  30. Jellinek DA, Freeman R. Perioperative care. In: Kaye AH, McL BP, editors. Operative Neurosurgery. Edinburgh: Churchill Livingstone; 2000. p. 15–32.Google Scholar
  31. Cornick JL. Anesthetic management of patients with neurological abnormalities. Compend Cont Ed Pract Vet. 1992;14:163–73.Google Scholar
  32. Walters FJM. Neuro anaesthesia – a review of the basic principles and current practices. Cent Afr J Med. 1990;36:44–51.PubMedGoogle Scholar
  33. Court MH, Dodman NH, Norman WM, Seeler DC. Anaesthesia and central nervous system disease in small animals part I: general considerations. Br Vet J. 1990;146:285–95.View ArticlePubMedGoogle Scholar
  34. Dzikiti TB. Intravenous anaesthesia in goats: a review. J S Afr Vet Assoc. 2013;84:1–8.View ArticleGoogle Scholar
  35. Langley MS, Heel RC. Propofol. A review of its pharmacodynamic and pharmacokinetic properties and use as an intravenous anaesthetic. Drugs. 1988;35:334–72.View ArticlePubMedGoogle Scholar
  36. Reid J, Nolan AM, Welsh E. Propofol as an induc- tion agent in the goat: a pharmacokinetic study. J Vet Pharmacol Therap. 1993;16:488–93.View ArticleGoogle Scholar
  37. Prassinos NN, Galatos AD, Raptopoulos D. A comparison of propofol, thiopental or ketamine as induction agents in goats. Vet Anaesth Analg. 2005;32:289–96.View ArticlePubMedGoogle Scholar
  38. Ferreira JP, Ndawana PS, Dzikiti LN, Dzikiti BT. Determination of the minimum infusion rate of propofol required to prevent purposeful movement of the extremities in response to a standardized noxious stimulus in goats. Vet Anaesth Analg. 2015; https://doi.org/10.1111/vaa.12327.
  39. Dzikiti TB, Stegmann GF, Dzikiti LN, Hellebrekers LJ. Effects of midazolam on isoflurane minimum alveolar concentration in goats. Small Rumin Res. 2011;97:104–9.View ArticleGoogle Scholar
  40. Carroll GL, Hooper RN, Slater MR, Hartsfield SM, Matthews NS. Detomidine-butorphanol-propofol for carotid artery transloca- tion and castration or ovariectomy in goats. Vet Surg. 1998;27:75–82.View ArticlePubMedGoogle Scholar
  41. Ndawana PS, Dzikiti TB, Zeiler GE, Dzikiti NL. Determination of minimum infusion rate (MIR) of alfaxalone required to prevent purposeful movement of the extremities in response to a standardised noxious stimulus in goats. Vet Anaesth Analg. 2015;42:65–71.View ArticlePubMedGoogle Scholar
  42. Hemmings HC Jr. Neuroprotection by Na channel blockade. J Neurosurg Anesthesiol. 2004;16:100–1.View ArticlePubMedGoogle Scholar
  43. Lei B, Popp S, Capuano-Waters C, Cottrell JE, Kass IS. Effects of delayed administration of low-dose lidocaine on transient focal cerebral ischemia in rats. Anesthesiology. 2002;97:1534–40.View ArticlePubMedGoogle Scholar

Copyright

© The Author(s). 2017

Advertisement